Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 5/20 | 0.42 |
| ▸ | ACHE | P22303 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.36 |
| ▸ | CD44 | P16070 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1698298 | 0.85 | TSHR (0.39) | CYP1A2CYP2A6CYP3A4TSHRACHE | |
| SCHEMBL6149952 | 0.83 | CD44 (0.50) | CYP1A2CYP2A6CYP3A4TSHRACHE | |
| SCHEMBL571847 | 0.83 | TRPA1 (0.50) | CYP1A2CYP2A6CYP3A4TSHRALDH1A1 | |
| SCHEMBL910072 | 0.83 | ALDH1A1 (0.41) | CYP1A2CYP2A6CYP3A4TSHRALDH1A1 | |
| SCHEMBL21201383 | 0.83 | ACHE (0.48) | CYP1A2CYP2A6CYP3A4TSHRACHE | |
| SCHEMBL11508761 | 0.81 | CYP3A4 (0.39) | CYP1A2CYP3A4TSHRACHETRPA1 | |
| SCHEMBL1535598 | 0.81 | GABRA1 (0.45) | CYP1A2CYP2A6CYP3A4ALDH1A1TDP1 | |
| SCHEMBL18191838 | 0.78 | ALDH1A1 (0.39) | CYP1A2CYP2A6CYP3A4TSHRALDH1A1 | |
| SCHEMBL5176727 | 0.78 | GABRA1 (0.35) | CYP1A2CYP2A6CYP3A4ALDH1A1CA1 | |
| SCHEMBL10533625 | 0.78 | GAA (0.37) | CYP1A2CYP2A6CYP3A4TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 617 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4347728-A1 | UV LED FREE RADICAL CURABLE INKJET INKS | AGFA NV (BE) | 2024-04-10 | — | — | EP | claimed |
| US-20240033318-A1 | PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION | OHIO STATE INNOVATION FOUNDATION | 2024-02-01 | — | — | US | claimed |
| US-20240025931-A1 | Acylphosphine Oxide Photoinitiators and Applications Thereof | AGFA NV (BE) | 2024-01-25 | — | — | US | claimed |
| CN-117440994-A | UV LED free radical curable inkjet ink | 爱克发有限公司 | 2024-01-23 | — | — | CN | claimed |
| US-20230416547-A1 | UV Curable Inkjet Inks and Inkjet Printing Methods | AGFA NV (BE) | 2023-12-28 | — | — | US | claimed |
| WO-2023232305-A1 | INKJET PRINTING METHODS | AGFA NV (BE) | 2023-12-07 | — | — | WO | claimed |
| EP-4286483-A1 | INKJET PRINTING METHODS | AGFA NV (BE) | 2023-12-06 | — | — | EP | claimed |
| EP-4247824-A1 | ACYLPHOSPHINE OXIDE PHOTOINITIATORS AND APPLICATIONS THEREOF | AGFA NV (BE) | 2023-09-27 | — | — | EP | claimed |
| EP-4247903-A1 | UV CURABLE INKJET INKS AND INKJET PRINTING METHODS | AGFA NV (BE) | 2023-09-27 | — | — | EP | claimed |
| CN-116438189-A | Acyl phosphine oxide photoinitiator and application thereof | 爱克发有限公司 | 2023-07-14 | — | — | CN | claimed |
| WO-1993018003-A1 | SUBSTITUED PIPECOLINIC ACID DERIVATIVES AS HIV PROTEASE INHIBITORS | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1993-09-16 | — | — | WO | claimed |
| EP-0560268-A1 | Substituted pipecolinic acid derivatives as HIV protease inhibitors | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1993-09-15 | — | — | EP | claimed |
| US-5049551-A | Antitumor | UBE INDUSTRIES, LTD. (JP) | 1991-09-17 | — | — | US | claimed |
| EP-0400610-A1 | 5-Fluorouracil derivatives | UBE INDUSTRIES, LTD. (JP) | 1990-12-05 | — | — | EP | claimed |
| US-4456755-A | ANTIBIOTICS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1984-06-26 | — | — | US | claimed |
| EP-0075629-A1 | Imidazole derivatives, their preparation, and their pharmaceutical compositions | Sumitomo Chemical Industries Ltd. (JP) | 1983-04-06 | — | — | EP | claimed |
| US-4361514-A | Carbon analogs of penicillin | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1982-11-30 | — | — | US | claimed |
| US-4282149-A | Carbon and oxygen analogs of penicillin | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1981-08-04 | — | — | US | claimed |
| US-4087444-A | Amides as ovulation inhibitors | ELI LILLY AND COMPANY (US) | 1978-05-02 | — | — | US | claimed |
| US-3975532-A | ANALGESIC | ICI UNITED STATES INC. (US) | 1976-08-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240025931-A1 | Acylphosphine Oxide Photoinitiators and Applications Thereof | DDO, PAM, SAT1 | CYP1A2 3478/4885CYP2A6 2784/4885CYP3A4 2409/4885 |
| US-20240033318-A1 | PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION | CHP1, NFATC1, PPP3R1 | CYP1A2 4838/4885CYP2A6 3581/4885CYP3A4 4535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.